Cargando…
Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model
Cardiac fibrosis is a significant global health problem with limited treatment choices. Although previous studies have shown that imatinib (IMA) inhibited cardiac fibrosis, the anti-fibrotic mechanisms have not been clearly uncovered. The aim of this study is to evaluate whether IMA attenuates cardi...
Autores principales: | Wang, Le-Xun, Yang, Xiao, Yue, Yuan, Fan, Tian, Hou, Jian, Chen, Guang-Xian, Liang, Meng-Ya, Wu, Zhong-Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453565/ https://www.ncbi.nlm.nih.gov/pubmed/28570599 http://dx.doi.org/10.1371/journal.pone.0178619 |
Ejemplares similares
-
Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis
por: Dai, Hui, et al.
Publicado: (2019) -
CD47 Deficiency Attenuates Isoproterenol-Induced Cardiac Remodeling in Mice
por: Zuo, Zhi, et al.
Publicado: (2019) -
Galangin Attenuates Isoproterenol-Induced Inflammation and Fibrosis in the Cardiac Tissue of Albino Wistar Rats
por: Thangaiyan, Radhiga, et al.
Publicado: (2020) -
MicroRNA-146a attenuates isoproterenol-induced cardiac fibrosis by inhibiting FGF2
por: Zhang, Hongliang, et al.
Publicado: (2022) -
Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy
por: Liu, Qian, et al.
Publicado: (2015)